ASTROCYTOMA
Clinical trials for ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental brain tumor combo shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called zotiraciclib (TG02) combined with the standard chemotherapy temozolomide in adults with recurrent anaplastic astrocytoma or glioblastoma. The goal was to find safe doses and see if the combination works better than temozolomide alone.…
Matched conditions: ASTROCYTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Brain tumor molecule may predict survival
Knowledge-focused TerminatedThis study looked at a molecule called microRNA-10b in people with gliomas, a type of brain tumor. Researchers wanted to see if higher levels of this molecule could help predict how long patients live or how their tumor behaves. They collected tumor, blood, and spinal fluid sampl…
Matched conditions: ASTROCYTOMA
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 08:05 UTC
-
Antifungal drug explored as brain tumor treatment – study halted early
Knowledge-focused TerminatedThis study looked at whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 adults with breast cancer that spread to the brain or with a type of brain tumor called glioma. The goal was to see if the drug could affect the tumor'…
Matched conditions: ASTROCYTOMA
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC